CENPN

Across TCGA pan-cancer cohorts, CENPN Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated CENPN data layer compared with 26 for mass-spec protein and 1 for mass-spec protein.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher CENPN Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated CENPN expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

BLCA, LUSC, and UCEC are the cancer types where CENPN Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Median	III,IV	0.130	0.684	<.001	24	view →
LUSC	DFS	Median	II,III,IV	0.135	0.663	.015	12	view →
UCEC	DFS	Median	All	1.000	0.627	.013	12	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

CENPN–BLCA (OS)

Open the BLCA breakdown →